Rare diseases
Investigational molecules
Locations
Back to Czechia12 clinical trials in Miroslav, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study of Brenipatide (LY3537031) in Adults with Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
CzechiaEfficacy and Safety of Depemokimab for Early Intervention in Adults and Adolescents with Type 2 Asthma at Risk of Exacerbations
CzechiaStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
CzechiaStudy of Verekitug to improve symptoms in patients with moderate to severe chronic obstructive pulmonary disease (COPD)
CzechiaStudy on the Effectiveness and Safety of Tanimilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CzechiaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
CzechiaStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on the Effectiveness and Safety of CHF 5993 Compared to CHF 1535 for Patients with Chronic Obstructive Pulmonary Disease (COPD)
CzechiaStudy on Tezepelumab for Reducing Steroid Use in Adults with Steroid-Dependent Asthma
CzechiaComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
CzechiaStudy on the Effectiveness and Safety of Camlipixant for Adults with Refractory or Unexplained Chronic Cough
CzechiaStudy on RPT193 for Adults with Moderate-to-Severe Asthma Partially Controlled by Inhaled Corticosteroids and Long-Acting Beta 2 Agonists
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials exploring new treatments for moderate-to-severe asthma, focusing on patients with partial control using standard therapies.
Research aims to evaluate novel therapeutic approaches for reducing dependency on conventional medications while maintaining effective symptom control.
Comprehensive research into Chronic Obstructive Pulmonary Disease treatments, examining both single and combination therapies.
Studies focus on developing enhanced treatment options for managing COPD symptoms and reducing disease progression.
Specialized investigations into refractory and unexplained chronic cough, testing innovative therapeutic solutions.
Research targets improving quality of life for patients with persistent cough conditions that resist conventional treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
